Notwithstanding major improvements in treatment modalities, the prognosis of patients with glioblastoma is poor. Hypofractionated radiation therapy as an alternative of the standard 6-week regimen could be an attractive approach as an effort to prevent tumor cell repopulation and reduction the total treatment period promoting patient comfort and convenience.
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
TREATMENT
Masking
NONE
Enrollment
58
Hypofractionated radiation therapy Total dose: 60 Gy (20 fractions / 3 Gy per fraction)
Instituto do Cancer do Estado de São Paulo (ICESP) - FMUSP
São Paulo, São Paulo, Brazil
RECRUITINGOverall survival
From date of the start of treatment to date of death due to any cause.
Time frame: 24 months
Progression-free survival
The time between the start of treatment and tumor progression or death due to any cause.
Time frame: 24 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.